Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",24989,1767,1.19 [1.13-1.25],8.549658233625385e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,25161,1772,1.46 [1.35-1.57],1.3164647675498208e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,25701,1811,1.52 [1.35-1.70],1.14800647593199e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,25403,1773,2.87 [2.49-3.31],1.8712426891599301e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,25613,1801,1.23 [1.16-1.31],6.866781609369033e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,22235,1580,1.98 [1.74-2.24],5.844219289366918e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,21736,1552,1.59 [1.43-1.77],7.191919566486299e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,25852,1817,2.90 [2.47-3.41],1.7899983705480763e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,24826,1742,1.16 [1.11-1.21],1.3022412415028178e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,25724,1819,1.60 [1.43-1.78],1.827000611119061e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",25565,1803,1.27 [1.21-1.33],2.0333641102304194e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",25512,1792,1.21 [1.18-1.25],4.5459033090739846e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,25820,1812,2.04 [1.65-2.53],8.04750675695557e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,25852,1817,1.62 [1.46-1.80],7.846046901538193e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,25026,1760,1.22 [1.16-1.28],3.7860686261847495e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,25613,1801,0.72 [0.66-0.78],2.3009491827954696e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,25512,1792,1.49 [1.37-1.62],3.591397415503172e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,25451,1778,2.17 [1.91-2.46],1.1421805144387797e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,22256,1575,1.81 [1.51-2.16],6.110328673805725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,22268,1588,1.39 [1.30-1.49],6.628938053120077e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",21631,1536,1.66 [1.46-1.89],2.6683684425810524e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,24989,1767,1.30 [1.22-1.38],3.5909938881084496e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,25451,1778,0.54 [0.48-0.61],6.849503096272541e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,21736,1552,2.11 [1.77-2.52],9.16088325266411e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,25564,1803,1.43 [1.33-1.53],1.7380536273116212e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,25873,1818,2.96 [2.44-3.60],4.614228146215471e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,25866,1814,1.42 [1.34-1.51],2.5843548017639973e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,25852,1817,0.66 [0.58-0.74],7.1390016916601885e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,25930,1825,1.89 [1.60-2.23],4.549171756589685e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,25519,1799,0.77 [0.72-0.82],1.0708270149029991e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,25852,1817,0.64 [0.56-0.73],1.0472824260376977e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,25613,1801,1.61 [1.42-1.82],2.6476303290545705e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,25921,1826,1.45 [1.30-1.61],1.2806238469469454e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,25547,1809,1.20 [1.15-1.25],7.957865139697313e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,25921,1826,1.22 [1.17-1.28],5.804293973745334e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,25724,1819,1.44 [1.33-1.56],6.110760906529706e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,25323,1796,1.47 [1.37-1.58],4.1220913028488735e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,25598,1805,1.29 [1.20-1.38],8.908330985430206e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,25886,1822,1.50 [1.33-1.70],9.042951180223339e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,25047,1768,1.63 [1.48-1.79],6.124223616648537e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,25671,1804,1.53 [1.38-1.69],8.163746320930904e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,25866,1814,1.48 [1.32-1.66],3.3886475395019474e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,25773,1810,1.49 [1.35-1.65],2.951091864349965e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,25852,1817,1.27 [1.19-1.37],2.6394687332916108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,25512,1792,1.87 [1.64-2.12],1.06848551337385e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,25558,1802,1.52 [1.33-1.73],4.970538083682384e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,25866,1814,1.57 [1.40-1.76],3.5808766300044005e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,22239,1578,1.57 [1.37-1.81],1.9689057606086558e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,25598,1805,2.09 [1.89-2.31],3.3511672727283115e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,25606,1800,1.89 [1.60-2.23],5.880633486164917e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,25451,1778,1.57 [1.47-1.69],5.938540868217194e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,25634,1801,1.83 [1.52-2.19],6.568872445778399e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,22149,1572,0.76 [0.72-0.80],1.401264942621586e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,24651,1741,1.52 [1.44-1.61],1.5396860784287623e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,22235,1580,1.51 [1.39-1.64],5.776668089809885e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,25161,1772,1.26 [1.17-1.36],4.82835669903631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,25512,1792,1.23 [1.15-1.32],7.599037133503107e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,22268,1588,2.42 [1.91-3.07],2.774030765408063e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,25613,1801,1.36 [1.23-1.49],2.774170808081811e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",22173,1569,1.71 [1.54-1.90],2.2379839905239905e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,22235,1580,1.22 [1.16-1.29],2.987766037180041e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,24999,1762,1.38 [1.32-1.44],4.958686878086734e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,25685,1817,1.54 [1.36-1.76],3.5273535775662204e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,25782,1811,1.90 [1.70-2.13],1.5794060026398754e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,22235,1580,1.29 [1.19-1.39],5.39523370705631e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,25451,1778,1.49 [1.33-1.68],1.335052744282264e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,25606,1800,1.62 [1.43-1.84],1.1639828886800745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,25598,1805,1.34 [1.26-1.41],7.393833834186975e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,25520,1793,1.97 [1.75-2.21],1.6100099771442665e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,24989,1767,1.32 [1.22-1.44],2.559160927542397e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,25930,1825,0.59 [0.50-0.68],1.5958488096223396e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,25696,1811,2.32 [1.93-2.79],3.174126970966882e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,25930,1825,1.77 [1.57-1.99],3.7982360098518925e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,25593,1813,2.09 [1.79-2.44],1.869816811922229e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,25747,1804,1.51 [1.35-1.70],4.152725140462666e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,25257,1778,1.40 [1.28-1.54],1.6551267618287494e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,25451,1778,1.42 [1.27-1.57],1.08122096215203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,25724,1819,1.64 [1.42-1.89],9.324522444991434e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,25650,1808,2.14 [1.87-2.46],5.6278008065559825e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,25248,1774,1.37 [1.25-1.51],6.001486516889465e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,23871,1690,1.72 [1.60-1.85],7.457083056886187e-46
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,25613,1801,1.73 [1.47-2.03],3.956476761565119e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,25593,1803,1.64 [1.44-1.86],3.4589773749802866e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,25598,1805,1.42 [1.32-1.52],1.7364333906573006e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,25880,1821,2.40 [2.02-2.85],1.924036214825781e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,25921,1826,1.70 [1.59-1.81],2.8907896827785606e-60
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",25512,1792,1.33 [1.22-1.45],3.1611000561117965e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,25866,1814,1.81 [1.53-2.13],1.5644589597193593e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,25243,1777,1.10 [1.07-1.13],4.578402844183256e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,25598,1805,1.51 [1.37-1.66],2.990783683003136e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,25512,1792,0.55 [0.49-0.62],2.0692116905646297e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,25395,1787,1.24 [1.16-1.32],4.786065763363881e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,25512,1792,1.60 [1.38-1.86],4.0377909431712847e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,25852,1817,1.50 [1.34-1.68],1.3127342759430504e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,25161,1772,1.72 [1.58-1.89],1.2311416267935992e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,21631,1536,2.40 [2.04-2.81],7.85253287461795e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,25559,1796,1.78 [1.55-2.06],2.546012569012436e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,25403,1773,1.81 [1.60-2.05],6.6211292805581066e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,25930,1825,0.39 [0.31-0.51],3.8504293814366266e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,22239,1578,1.66 [1.44-1.90],1.023700894339405e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,24876,1757,1.18 [1.13-1.24],5.364274892856662e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,24711,1732,1.66 [1.45-1.90],1.7573577181097032e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,25930,1825,1.63 [1.40-1.90],4.4575392330646055e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,25814,1816,1.51 [1.32-1.71],7.262121406665793e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,25658,1809,2.36 [1.88-2.97],1.880717459495124e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",25593,1813,1.19 [1.14-1.23],7.461310680530845e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",22239,1578,1.37 [1.26-1.50],2.797488736595943e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",25930,1825,1.41 [1.30-1.53],1.357280987482083e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,22239,1578,2.30 [1.97-2.70],4.717264932947559e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,25581,1799,1.67 [1.45-1.92],6.250148931413508e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,25921,1826,0.70 [0.63-0.78],2.5516869229204363e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,25822,1816,1.23 [1.19-1.26],4.2288207917358624e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,25808,1814,1.25 [1.17-1.32],6.003315497157035e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,25671,1804,1.84 [1.53-2.21],6.343154158433008e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,22256,1575,1.35 [1.26-1.45],1.577055454088206e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,21631,1536,2.13 [1.73-2.62],8.256483830124381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,25562,1808,2.08 [1.84-2.36],1.4799924429347794e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,25671,1804,1.61 [1.43-1.81],8.4665972458209895e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,25866,1814,1.42 [1.30-1.55],5.063731074839912e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,25512,1792,1.68 [1.46-1.93],5.15778860196215e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,22173,1569,1.21 [1.17-1.25],1.488462453149147e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,21211,1513,1.53 [1.43-1.63],1.5609510369731663e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,25930,1825,1.32 [1.22-1.44],2.2390227587270025e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,25822,1816,2.00 [1.73-2.31],3.3466739362229047e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,25559,1796,1.45 [1.35-1.56],8.150344518553634e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,21691,1547,1.56 [1.38-1.76],4.842162726167556e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,21711,1537,1.38 [1.26-1.52],1.0364875857467323e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,22130,1568,1.34 [1.24-1.46],2.658386177214233e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,25161,1772,1.27 [1.19-1.35],1.2859524575363454e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,22130,1568,1.30 [1.21-1.40],3.394977862859424e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,25479,1791,1.73 [1.47-2.04],7.044067901957875e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",25512,1792,1.29 [1.21-1.37],4.138968600437216e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,22168,1563,0.45 [0.35-0.57],3.287715965451048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,25820,1812,1.40 [1.31-1.49],3.5465819185875365e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,25606,1800,1.83 [1.63-2.05],1.3454519368858778e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,21736,1552,1.96 [1.67-2.30],1.9884815040427911e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,25921,1826,1.78 [1.60-1.97],5.1442348498318015e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,24989,1767,0.69 [0.61-0.77],6.056724604578308e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,25396,1790,1.64 [1.40-1.92],7.622338639802008e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,25492,1798,2.19 [1.95-2.47],7.755087041931267e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,25613,1801,1.70 [1.55-1.86],1.0395382430277556e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,25852,1817,1.39 [1.27-1.52],1.4208001212979546e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,21619,1533,1.98 [1.81-2.18],2.4033760017505142e-48
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,25880,1825,1.24 [1.16-1.32],4.2697503972400254e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,25278,1777,2.00 [1.86-2.14],2.5008352634892678e-82
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,25930,1825,1.75 [1.54-1.98],1.1962675096928249e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,25613,1801,1.78 [1.58-1.99],6.801998213981689e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,25613,1801,1.78 [1.56-2.03],3.065173819490063e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,22239,1578,1.23 [1.17-1.30],2.205506340955737e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,25724,1819,1.87 [1.63-2.15],2.350522532660373e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,25598,1805,1.86 [1.65-2.09],4.484962936288721e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,25504,1809,1.31 [1.21-1.43],1.154081487375262e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,25691,1811,1.70 [1.49-1.94],5.0070394904568525e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,24979,1758,1.20 [1.14-1.27],3.1431556928087136e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,25547,1807,1.30 [1.22-1.38],2.044338890334603e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,22130,1568,1.31 [1.22-1.40],9.731512185262856e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,25451,1792,1.67 [1.51-1.85],2.0744904967841532e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,25598,1805,1.66 [1.49-1.84],7.333691714912725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,25512,1792,1.30 [1.24-1.35],6.603174136413344e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,25606,1800,0.76 [0.71-0.82],5.11645640397202e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,22130,1568,1.43 [1.30-1.57],4.655291505260532e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,21736,1552,1.50 [1.37-1.64],1.2964419591467205e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,25613,1801,0.65 [0.59-0.72],1.2550771129942962e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,25590,1798,1.43 [1.30-1.58],1.6392889662864374e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,25044,1752,1.43 [1.31-1.56],4.715023732166814e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",25512,1792,1.17 [1.12-1.22],2.8632613415656725e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",25565,1803,1.21 [1.14-1.28],8.281862697096376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,25593,1813,1.38 [1.26-1.51],1.1744300586542377e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,25724,1819,1.45 [1.29-1.62],1.6900172011255164e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,25873,1818,1.58 [1.48-1.68],1.8011706819396868e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,25405,1777,1.55 [1.37-1.74],8.23476870467886e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,24805,1751,1.37 [1.25-1.50],5.283828661691015e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,25593,1813,1.45 [1.36-1.56],9.701728537114806e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,25594,1810,1.77 [1.57-1.99],1.959508118221945e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,25724,1819,1.55 [1.40-1.73],3.725068685268583e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,25581,1799,1.59 [1.40-1.80],1.2773737523172301e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,25143,1785,1.41 [1.28-1.55],4.861704647028742e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,22268,1588,1.75 [1.47-2.08],3.337156196586355e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,25512,1792,1.44 [1.31-1.60],6.398833147614775e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,25143,1785,0.64 [0.58-0.71],8.770821867510176e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,25852,1817,1.26 [1.19-1.33],1.7583067773084398e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,25454,1804,1.63 [1.41-1.88],2.002989540665076e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,25638,1816,1.58 [1.37-1.81],7.165723782725731e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,25587,1799,1.33 [1.23-1.43],5.75624572099945e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,25606,1800,1.38 [1.26-1.51],1.3484267003511608e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,25512,1792,1.22 [1.16-1.28],1.1101823209004981e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,25666,1803,1.68 [1.56-1.80],2.988373867513882e-49
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,25124,1769,1.44 [1.32-1.58],3.306815503431921e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,25827,1813,1.21 [1.16-1.27],1.1738446944808432e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,25572,1800,1.28 [1.20-1.37],5.6781211895277934e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,22256,1575,1.79 [1.52-2.11],2.136797077897881e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,25475,1791,1.34 [1.27-1.42],1.5113882644046203e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,25539,1799,1.31 [1.23-1.39],3.033681049330907e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,25866,1814,1.42 [1.30-1.55],1.6784996847245274e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,25161,1772,0.77 [0.71-0.83],4.5840276863253046e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,25143,1785,1.23 [1.17-1.29],3.173189309441936e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,25677,1818,1.44 [1.34-1.55],2.8478399509139797e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,25866,1814,0.64 [0.57-0.71],3.82940655082416e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,25581,1799,1.76 [1.55-2.00],1.5012971621783138e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,24948,1758,1.35 [1.24-1.47],4.22764791107272e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,21243,1514,2.08 [1.78-2.44],1.5034558054027388e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,21872,1552,2.18 [2.01-2.38],3.2033847194262954e-73
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,25613,1801,1.59 [1.40-1.80],3.19304219351858e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,25606,1800,1.37 [1.25-1.50],1.0504689372269938e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,22173,1569,1.59 [1.39-1.83],1.9183492692481198e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,25866,1814,0.54 [0.44-0.65],7.209066991745317e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,22205,1573,1.94 [1.76-2.14],3.9067954996789236e-40
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,25367,1786,1.19 [1.13-1.26],4.339170455313611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,25724,1819,0.74 [0.67-0.81],1.5304183502667434e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,25512,1792,0.76 [0.72-0.81],3.2955680039288095e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,22187,1583,2.58 [2.06-3.23],2.053155627657336e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,25638,1816,1.77 [1.57-2.00],2.481420120233304e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,25467,1797,1.28 [1.22-1.35],2.7692799678276726e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,25738,1812,2.03 [1.67-2.47],1.4052676129906528e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,22173,1569,1.71 [1.53-1.90],1.7469664038989554e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,22256,1575,1.34 [1.25-1.44],6.030483321363865e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,25787,1817,1.32 [1.21-1.44],3.967754687801216e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,25247,1777,1.32 [1.22-1.41],6.327824827276014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,25284,1787,2.16 [1.97-2.36],5.205612942020277e-63
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,25606,1800,1.68 [1.45-1.94],1.4525226550899156e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,25606,1800,1.50 [1.35-1.66],1.802810784855829e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,25613,1801,1.29 [1.19-1.39],2.523282252397584e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,25671,1804,2.26 [1.98-2.58],4.8819643664774835e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,25837,1817,1.35 [1.25-1.47],8.564959937217432e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,25424,1806,2.38 [2.11-2.69],3.3691007208104774e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,25161,1772,1.49 [1.32-1.68],7.10046589292953e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,22235,1580,1.74 [1.54-1.97],1.2508045843117385e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,25743,1815,1.55 [1.36-1.76],1.9667275953126883e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,25691,1811,1.31 [1.23-1.40],6.964188770164543e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,25512,1807,2.17 [1.99-2.37],5.5099990210624575e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,22041,1564,1.89 [1.68-2.13],2.397922775458758e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,22239,1578,1.68 [1.46-1.94],6.466642475322551e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,25866,1814,1.49 [1.36-1.64],8.63877996442081e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,21528,1521,1.17 [1.12-1.23],1.2704722789766612e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,25738,1812,1.42 [1.32-1.53],1.1515623766529629e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,22205,1573,1.48 [1.34-1.64],4.3972303705266485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,25512,1792,1.27 [1.18-1.35],5.506574161415043e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,25464,1797,1.42 [1.31-1.53],6.966291891640017e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,25930,1825,1.32 [1.23-1.41],4.321163222563109e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,25930,1825,1.23 [1.15-1.31],1.4043189205547715e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,25638,1816,1.49 [1.38-1.62],9.886205972006128e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,25606,1800,1.80 [1.57-2.07],1.862794878337869e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,25613,1801,1.24 [1.18-1.32],3.6817302310717e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,22101,1566,1.78 [1.53-2.06],3.352634902936833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,21631,1536,2.08 [1.78-2.41],2.7529979693591517e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,24989,1767,1.32 [1.23-1.42],3.201004618065076e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,25451,1778,1.52 [1.35-1.70],1.7771533112392209e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,24955,1737,1.70 [1.49-1.93],1.3818900053510652e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,25654,1817,0.69 [0.66-0.73],6.443200213987162e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,21736,1552,1.88 [1.58-2.24],7.153979055987745e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,25685,1817,1.26 [1.21-1.31],5.282347978080692e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,25790,1811,1.29 [1.19-1.39],3.0417143073806985e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,25930,1825,1.41 [1.29-1.53],1.6268327845062038e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,22125,1564,1.55 [1.37-1.76],1.0388014987396448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,22203,1586,2.42 [1.88-3.11],6.722503077577565e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,22222,1587,1.83 [1.55-2.16],1.2914103898056117e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,22222,1587,2.25 [1.75-2.89],1.9556944283208438e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,24989,1767,1.55 [1.46-1.64],1.912134058703543e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,22235,1580,2.14 [1.80-2.53],1.8974645682497096e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,25724,1819,1.41 [1.29-1.55],6.65880655027953e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,25613,1801,2.15 [1.86-2.48],1.5313698513813934e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,21601,1534,0.53 [0.45-0.61],1.2889169587203483e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,25852,1817,0.68 [0.62-0.75],7.896610261414833e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,25741,1802,1.45 [1.35-1.55],1.0051879196460531e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",25606,1800,1.42 [1.28-1.57],1.792561984546791e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,25606,1800,1.62 [1.49-1.76],4.5725385575242114e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,25516,1795,1.89 [1.64-2.19],8.169947815539335e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,25638,1816,1.87 [1.65-2.11],1.3648797413744356e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,25486,1791,1.65 [1.47-1.86],6.913028645215833e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,25581,1799,0.88 [0.85-0.91],8.179743761319393e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",25930,1825,1.77 [1.55-2.03],8.101869724598702e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,25598,1805,1.24 [1.17-1.32],1.119579350505794e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,25606,1800,1.97 [1.80-2.16],6.243789283470447e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,25489,1794,1.29 [1.23-1.35],1.5530473329113628e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,25685,1817,1.60 [1.51-1.70],1.6485615947903455e-55
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,25579,1801,1.33 [1.23-1.44],3.4929178630229534e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,25598,1805,1.43 [1.33-1.53],5.25808489309784e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,25873,1818,1.42 [1.28-1.57],9.308050101860926e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,25671,1804,1.57 [1.39-1.77],2.0270936848694277e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,25606,1800,1.49 [1.34-1.66],2.43538991158876e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,25316,1783,2.03 [1.76-2.34],5.2624622206093763e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,25606,1800,1.57 [1.43-1.72],1.752422602439548e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,25451,1778,1.94 [1.72-2.18],1.2953075670191414e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,25451,1778,1.68 [1.63-1.73],6.819359434609546e-254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,25593,1813,1.77 [1.57-1.99],2.222299483482012e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,25671,1804,1.75 [1.57-1.95],7.812120173844395e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,25638,1816,1.48 [1.34-1.64],1.195279801256944e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,25638,1816,1.66 [1.45-1.89],3.627495495145321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,25606,1800,2.01 [1.77-2.29],1.1281556348403836e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,25606,1800,1.49 [1.39-1.60],1.0889879483624632e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,25451,1778,1.48 [1.40-1.58],5.432329737836249e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,25451,1778,1.42 [1.29-1.57],2.5410115846437288e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,25724,1819,1.80 [1.56-2.08],5.958784598844303e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,25880,1821,1.87 [1.64-2.14],1.591268052785523e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,25451,1778,0.65 [0.59-0.71],8.612909433345474e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,25430,1804,1.46 [1.37-1.56],2.0833406080178203e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,25593,1813,1.68 [1.57-1.80],2.673499914002664e-51
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,25451,1778,1.46 [1.31-1.62],3.401309302420776e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,25832,1820,1.27 [1.19-1.35],2.080294804716735e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,22130,1568,1.47 [1.36-1.59],1.0215858959495666e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,25573,1795,1.69 [1.52-1.87],2.175116793932009e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,25822,1816,1.64 [1.50-1.79],6.880244141611295e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,24291,1694,2.01 [1.84-2.20],2.200750095018223e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",25366,1768,0.66 [0.60-0.73],1.220889097748143e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,22173,1569,1.95 [1.64-2.32],4.0643361929298295e-14
